Cargando…

Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer

BACKGROUND: Although transplant benefit appears superior for patients with advanced hepatocellular cancer (HCC), liver transplantation remains limited to selected low-risk HCC patients to keep their outcomes similar to heterogeneous group of non-HCC patients. The purpose of this study was to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Grąt, Michał, Stypułkowski, Jan, Patkowski, Waldemar, Wronka, Karolina M., Bik, Emil, Krasnodębski, Maciej, Masior, Łukasz, Lewandowski, Zbigniew, Wasilewicz, Michał, Grąt, Karolina, Krawczyk, Marek, Zieniewicz, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596049/
https://www.ncbi.nlm.nih.gov/pubmed/28695391
http://dx.doi.org/10.1245/s10434-017-5989-x
_version_ 1783263470953693184
author Grąt, Michał
Stypułkowski, Jan
Patkowski, Waldemar
Wronka, Karolina M.
Bik, Emil
Krasnodębski, Maciej
Masior, Łukasz
Lewandowski, Zbigniew
Wasilewicz, Michał
Grąt, Karolina
Krawczyk, Marek
Zieniewicz, Krzysztof
author_facet Grąt, Michał
Stypułkowski, Jan
Patkowski, Waldemar
Wronka, Karolina M.
Bik, Emil
Krasnodębski, Maciej
Masior, Łukasz
Lewandowski, Zbigniew
Wasilewicz, Michał
Grąt, Karolina
Krawczyk, Marek
Zieniewicz, Krzysztof
author_sort Grąt, Michał
collection PubMed
description BACKGROUND: Although transplant benefit appears superior for patients with advanced hepatocellular cancer (HCC), liver transplantation remains limited to selected low-risk HCC patients to keep their outcomes similar to heterogeneous group of non-HCC patients. The purpose of this study was to assess the rationale for current policy of restricting access to liver transplantation to minority of HCC patients based on utility principle. METHODS: This retrospective cohort study comprised 1246 liver transplant recipients, including 206 HCC and 1040 non-HCC patients. Patient survival was the primary outcome measure. Patients with HCC and benign diseases were divided into low-, moderate-, and high-risk subgroups basing on independent risk factors for disease-free survival and model for end-stage liver disease (MELD) score (<30, 30–40, >40), respectively. RESULTS: MELD (p < 0.001) and presence of HCC (p = 0.008) were independent risk factors for early and late mortality, respectively. Total tumor volume (p = 0.008) and alpha-fetoprotein (p = 0.013) were independent predictors of recurrence and mortality used for division of HCC patients into low-, moderate-, and high-risk subgroups, with disease-free survival rates of 74.9% (5 years), 51.7% (5 years), and 8.0% (3 years), respectively (p < 0.001). There were no differences in 5-year overall survival between low-risk HCC (74.9%) and non-HCC (81.9%) patients (p = 0.210), moderate-risk HCC (63.3%) and non-HCC (68.0%) patients (p = 0.372), and high-risk HCC (55.0%) and non-HCC (56.0%) patients (p = 0.559). CONCLUSIONS: The principle of utility is unequally applied for restriction of access to liver transplantation for HCC patients. The results provide rationale for discussion on reinitiation of liver transplantation for advanced HCCs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1245/s10434-017-5989-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5596049
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-55960492017-09-26 Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer Grąt, Michał Stypułkowski, Jan Patkowski, Waldemar Wronka, Karolina M. Bik, Emil Krasnodębski, Maciej Masior, Łukasz Lewandowski, Zbigniew Wasilewicz, Michał Grąt, Karolina Krawczyk, Marek Zieniewicz, Krzysztof Ann Surg Oncol Hepatobiliary Tumors BACKGROUND: Although transplant benefit appears superior for patients with advanced hepatocellular cancer (HCC), liver transplantation remains limited to selected low-risk HCC patients to keep their outcomes similar to heterogeneous group of non-HCC patients. The purpose of this study was to assess the rationale for current policy of restricting access to liver transplantation to minority of HCC patients based on utility principle. METHODS: This retrospective cohort study comprised 1246 liver transplant recipients, including 206 HCC and 1040 non-HCC patients. Patient survival was the primary outcome measure. Patients with HCC and benign diseases were divided into low-, moderate-, and high-risk subgroups basing on independent risk factors for disease-free survival and model for end-stage liver disease (MELD) score (<30, 30–40, >40), respectively. RESULTS: MELD (p < 0.001) and presence of HCC (p = 0.008) were independent risk factors for early and late mortality, respectively. Total tumor volume (p = 0.008) and alpha-fetoprotein (p = 0.013) were independent predictors of recurrence and mortality used for division of HCC patients into low-, moderate-, and high-risk subgroups, with disease-free survival rates of 74.9% (5 years), 51.7% (5 years), and 8.0% (3 years), respectively (p < 0.001). There were no differences in 5-year overall survival between low-risk HCC (74.9%) and non-HCC (81.9%) patients (p = 0.210), moderate-risk HCC (63.3%) and non-HCC (68.0%) patients (p = 0.372), and high-risk HCC (55.0%) and non-HCC (56.0%) patients (p = 0.559). CONCLUSIONS: The principle of utility is unequally applied for restriction of access to liver transplantation for HCC patients. The results provide rationale for discussion on reinitiation of liver transplantation for advanced HCCs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1245/s10434-017-5989-x) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-07-10 2017 /pmc/articles/PMC5596049/ /pubmed/28695391 http://dx.doi.org/10.1245/s10434-017-5989-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Hepatobiliary Tumors
Grąt, Michał
Stypułkowski, Jan
Patkowski, Waldemar
Wronka, Karolina M.
Bik, Emil
Krasnodębski, Maciej
Masior, Łukasz
Lewandowski, Zbigniew
Wasilewicz, Michał
Grąt, Karolina
Krawczyk, Marek
Zieniewicz, Krzysztof
Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
title Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
title_full Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
title_fullStr Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
title_full_unstemmed Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
title_short Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
title_sort challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
topic Hepatobiliary Tumors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596049/
https://www.ncbi.nlm.nih.gov/pubmed/28695391
http://dx.doi.org/10.1245/s10434-017-5989-x
work_keys_str_mv AT gratmichał challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT stypułkowskijan challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT patkowskiwaldemar challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT wronkakarolinam challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT bikemil challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT krasnodebskimaciej challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT masiorłukasz challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT lewandowskizbigniew challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT wasilewiczmichał challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT gratkarolina challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT krawczykmarek challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer
AT zieniewiczkrzysztof challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer